Ian Dunn to Cell Line, Tumor
This is a "connection" page, showing publications Ian Dunn has written about Cell Line, Tumor.
Connection Strength
0.520
-
Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling. Cell Commun Signal. 2017 09 18; 15(1):34.
Score: 0.108
-
Genomic profile of human meningioma cell lines. PLoS One. 2017; 12(5):e0178322.
Score: 0.105
-
A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity. Proc Natl Acad Sci U S A. 2025 May 06; 122(18):e2427073122.
Score: 0.046
-
Physical Forces in Glioblastoma Migration: A Systematic Review. Int J Mol Sci. 2022 Apr 06; 23(7).
Score: 0.037
-
GATA2 Regulates Constitutive PD-L1 and PD-L2 Expression in Brain Tumors. Sci Rep. 2020 06 03; 10(1):9027.
Score: 0.032
-
Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease. Clin Cancer Res. 2020 03 01; 26(5):1141-1151.
Score: 0.031
-
The genomic landscape of schwannoma. Nat Genet. 2016 11; 48(11):1339-1348.
Score: 0.025
-
High incidence of TERT mutation in brain tumor cell lines. Brain Tumor Pathol. 2016 Jul; 33(3):222-7.
Score: 0.024
-
Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proc Natl Acad Sci U S A. 2013 May 14; 110(20):8188-93.
Score: 0.020
-
Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM. Proc Natl Acad Sci U S A. 2010 Jun 22; 107(25):11501-6.
Score: 0.016
-
CK1epsilon is required for breast cancers dependent on beta-catenin activity. PLoS One. 2010 Feb 01; 5(2):e8979.
Score: 0.016
-
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009 Nov 05; 462(7269):108-12.
Score: 0.016
-
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell. 2009 Jul 07; 16(1):21-32.
Score: 0.015
-
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell. 2009 May 29; 137(5):821-34.
Score: 0.015
-
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature. 2008 Sep 25; 455(7212):547-51.
Score: 0.014